Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Dr. Jeff Jones on the Importance of Biomarker Testing Before Treating Chronic Lymphocytic Leukemia (CLL) or Any Other Cancer

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

In this short but pithy news interview, Dr. Jeff Jones from Ohio State explains why it so very important to know the details of your cancer before starting on any treatment.

It could be a matter of life or death.

Please enjoy this brief and helpful interview:

You can access it here.